Terms: = Ovarian cancer AND CEBPA, CEBP, 1050, C/EBP-alpha, P49715
56 results:
1. Point-of-care testing: a disposable label-free electrochemical CA125 and HE4 immunosensors for early detection of ovarian cancer.
Bilgi Kamaç M; Altun M; Yılmaz M; Yılmaz Aktan A; Aktan S; Sezgintürk MK
Biomed Microdevices; 2023 May; 25(2):18. PubMed ID: 37140852
[TBL] [Abstract] [Full Text] [Related]
2. De novo myeloid sarcoma mimicking gynecological tumors: a retrospective case series of eight patients.
Gu Y; Zheng H; Mo S; Guo T; Chen L; Yang J; Xiang Y
BMC Womens Health; 2023 Mar; 23(1):141. PubMed ID: 36978050
[TBL] [Abstract] [Full Text] [Related]
3. Graphene Oxide Enhances Biogenesis and Release of Exosomes in Human ovarian cancer Cells.
Gurunathan S; Kim JH
Int J Nanomedicine; 2022; 17():5697-5731. PubMed ID: 36466784
[TBL] [Abstract] [Full Text] [Related]
4. Knockdown of ENTPD5 inhibits tumor metastasis and growth via regulating the GRP78/p-eIF-2α/CHOP pathway in serous ovarian cancer.
Chen X; Zha Z; Wang Y; Chen Y; Pang M; Huang L; Chen Y
J Ovarian Res; 2022 Jun; 15(1):69. PubMed ID: 35668504
[TBL] [Abstract] [Full Text] [Related]
5. [Expression and significance of GLI1 and Shh in the malignant transformation of ovarian endometriosis].
Zhao F; Yu XP; Zhao H; Song BB; Lyu AW; Zhang SH; Wang LM
Zhonghua Fu Chan Ke Za Zhi; 2022 Feb; 57(2):125-132. PubMed ID: 35184473
[No Abstract] [Full Text] [Related]
6. CCAAT enhancer binding protein α suppresses proliferation, metastasis, and epithelial-mesenchymal transition of ovarian cancer cells via suppressing the Wnt/β-catenin signaling.
Zhang LM; Li M; Tian CC; Wang TT; Mi SF
Neoplasma; 2021 May; 68(3):602-612. PubMed ID: 33780265
[TBL] [Abstract] [Full Text] [Related]
7. Biomarkers and Strategies for Early Detection of ovarian cancer.
Bast RC; Lu Z; Han CY; Lu KH; Anderson KS; Drescher CW; Skates SJ
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2504-2512. PubMed ID: 33051337
[TBL] [Abstract] [Full Text] [Related]
8. KAT6A amplifications are associated with shorter progression-free survival and overall survival in patients with endometrial serous carcinoma.
Saglam O; Tang Z; Tang G; Medeiros LJ; Toruner GA
PLoS One; 2020; 15(9):e0238477. PubMed ID: 32877461
[TBL] [Abstract] [Full Text] [Related]
9. JAM-A Acts via C/EBP-α to Promote Claudin-5 Expression and Enhance Endothelial Barrier Function.
Kakogiannos N; Ferrari L; Giampietro C; Scalise AA; Maderna C; Ravà M; Taddei A; Lampugnani MG; Pisati F; Malinverno M; Martini E; Costa I; Lupia M; Cavallaro U; Beznoussenko GV; Mironov AA; Fernandes B; Rudini N; Dejana E; Giannotta M
Circ Res; 2020 Sep; 127(8):1056-1073. PubMed ID: 32673519
[TBL] [Abstract] [Full Text] [Related]
10. Family Study Designs Informed by Tumor Heterogeneity and Multi-cancer Pleiotropies: The Power of the Utah Population Database.
Hanson HA; Leiser CL; Madsen MJ; Gardner J; Knight S; Cessna M; Sweeney C; Doherty JA; Smith KR; Bernard PS; Camp NJ
Cancer Epidemiol Biomarkers Prev; 2020 Apr; 29(4):807-815. PubMed ID: 32098891
[TBL] [Abstract] [Full Text] [Related]
11. Hematological toxicities associated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Wong EYT; Tan GHC; Kumar M; Teo MCC
Asia Pac J Clin Oncol; 2020 Apr; 16(2):e38-e46. PubMed ID: 31693307
[TBL] [Abstract] [Full Text] [Related]
12. Incidence of occult malignancies identified during hysterectomies performed for benign indications.
Topdagi Yilmaz EP; Cimilli Senocak GN; Topdagi YE; Aynaoglu Yildiz G; Kumtepe Y
J Gynecol Obstet Hum Reprod; 2020 Mar; 49(3):101620. PubMed ID: 31449888
[TBL] [Abstract] [Full Text] [Related]
13. Survival and prognostic factors in patients with recurrent low-grade epithelial ovarian cancer: An analysis of five prospective phase II/III trials of NOGGO metadata base.
Canaz E; Grabowski JP; Richter R; Braicu EI; Chekerov R; Sehouli J
Gynecol Oncol; 2019 Sep; 154(3):539-546. PubMed ID: 31230821
[TBL] [Abstract] [Full Text] [Related]
14. Analysis of polymorphisms in genes associated with the FA/BRCA pathway in three patients with multiple primary malignant neoplasms.
Wang L; Wang H; Wang T; Liu J; Chen W; Wang Y; Chen C; Zhu H; Dai P
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1101-1112. PubMed ID: 30942098
[TBL] [Abstract] [Full Text] [Related]
15. ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repression.
Cao Y; Trillo-Tinoco J; Sierra RA; Anadon C; Dai W; Mohamed E; Cen L; Costich TL; Magliocco A; Marchion D; Klar R; Michel S; Jaschinski F; Reich RR; Mehrotra S; Cubillos-Ruiz JR; Munn DH; Conejo-Garcia JR; Rodriguez PC
Nat Commun; 2019 Mar; 10(1):1280. PubMed ID: 30894532
[TBL] [Abstract] [Full Text] [Related]
16. DAXX promotes ovarian cancer ascites cell proliferation and migration by activating the ERK signaling pathway.
Liu SB; Lin XP; Xu Y; Shen ZF; Pan WW
J Ovarian Res; 2018 Oct; 11(1):90. PubMed ID: 30336783
[TBL] [Abstract] [Full Text] [Related]
17. Common Genetic Variation and Susceptibility to ovarian cancer: Current Insights and Future Directions.
Kar SP; Berchuck A; Gayther SA; Goode EL; Moysich KB; Pearce CL; Ramus SJ; Schildkraut JM; Sellers TA; Pharoah PDP
Cancer Epidemiol Biomarkers Prev; 2018 Apr; 27(4):395-404. PubMed ID: 28615364
[TBL] [Abstract] [Full Text] [Related]
18. A final report of a phase I study of veliparib (ABT-888) in combination with low-dose fractionated whole abdominal radiation therapy (LDFWAR) in patients with advanced solid malignancies and peritoneal carcinomatosis with a dose escalation in ovarian and fallopian tube cancers.
Reiss KA; Herman JM; Armstrong D; Zahurak M; Fyles A; Brade A; Milosevic M; Dawson LA; Scardina A; Fischer P; Hacker-Prietz A; Kinders RJ; Wang L; Chen A; Temkin S; Horiba N; Stayner LA; Siu LL; Azad NS
Gynecol Oncol; 2017 Mar; 144(3):486-490. PubMed ID: 28109627
[TBL] [Abstract] [Full Text] [Related]
19. The significance of c.690G>T polymorphism (rs34529039) and expression of the cebpa gene in ovarian cancer outcome.
Konopka B; Szafron LM; Kwiatkowska E; Podgorska A; Zolocinska A; Pienkowska-Grela B; Dansonka-Mieszkowska A; Balcerak A; Lukasik M; Stachurska A; Timorek A; Spiewankiewicz B; El-Bahrawy M; Kupryjanczyk J
Oncotarget; 2016 Oct; 7(41):67412-67424. PubMed ID: 27602952
[TBL] [Abstract] [Full Text] [Related]
20. Myricetin induces apoptosis via endoplasmic reticulum stress and DNA double-strand breaks in human ovarian cancer cells.
Xu Y; Xie Q; Wu S; Yi D; Yu Y; Liu S; Li S; Li Z
Mol Med Rep; 2016 Mar; 13(3):2094-100. PubMed ID: 26782830
[TBL] [Abstract] [Full Text] [Related]
[Next]
